Palatin Technologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTN and other ETFs, options, and stocks.About PTN
Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin receptor system. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, which is used for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD).
CEOCarl Spana
CEOCarl Spana
Employees29
Employees29
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded1986
Founded1986
Employees29
Employees29
PTN Key Statistics
Market cap38.29M
Market cap38.29M
Price-Earnings ratio-1.67
Price-Earnings ratio-1.67
Dividend yield—
Dividend yield—
Average volume129.46K
Average volume129.46K
High today$22.70
High today$22.70
Low today$17.11
Low today$17.11
Open price$17.43
Open price$17.43
Volume89.25K
Volume89.25K
52 Week high$72.50
52 Week high$72.50
52 Week low$1.75
52 Week low$1.75
Stock Snapshot
With a market cap of 38.29M, Palatin Technologies(PTN) trades at $22.07. The stock has a price-to-earnings ratio of -1.67.
On 2025-12-04, Palatin Technologies(PTN) stock traded between a low of $17.11 and a high of $22.70. Shares are currently priced at $22.07, which is +29.0% above the low and -2.8% below the high.
The Palatin Technologies(PTN)'s current trading volume is 89.25K, compared to an average daily volume of 129.46K.
During the past year, Palatin Technologies(PTN) stock moved between $1.75 at its lowest and $72.50 at its peak.
During the past year, Palatin Technologies(PTN) stock moved between $1.75 at its lowest and $72.50 at its peak.
People also own
Based on the portfolios of people who own PTN. This list is generated using Robinhood data, and it’s not a recommendation.